Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer
about
Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settingsPerformance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in CubaRapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® SystemAn Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 QuasispeciesSimultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assaySequencing data and MLPA analysis data in support of the effectiveness and reliability of an asymmetric PCR-Based approach in preparing long MLPA probes.Sequence analysis of coding and 3' and 5' flanking regions of the epithelial sodium channel alpha, beta, and gamma genes in Dahl S versus R rats.Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infantsHigh failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity.Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.LETTER TO THE EDITOR Performance of the ViroSeq® HIV-1 Genotyping System v2.0 in Central Africa.Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs.Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010.Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats.Web resources for HIV type 1 genotypic-resistance test interpretation.Description of two commercially available assays for genotyping of HIV-1.HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa.Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
P2860
Q28478154-D176A057-98B8-461E-8599-7ECDB8C45057Q28543384-4958F009-7EE4-4384-8C2A-BB8F09CFD611Q28551441-3252F210-EB9C-4895-90AC-96562F242719Q28554999-36D877A7-081E-4178-AFA7-A0248516BBE2Q28660673-63092D8B-160D-47D3-828A-B9D2F07646ADQ30983403-3DC4BEAF-5BB9-4B2A-8C73-77D42E8F5529Q33288878-1A83CBE6-B9A7-4856-AE2E-E709E8111867Q33561750-17B5C230-0823-428B-A5DE-93DF9C8EF081Q35066913-B0196D21-BF8D-40DA-8EA4-EBF2CF0BB4B1Q35102225-9B2969CB-1759-49E4-A2D1-263D2036671CQ35157767-41FCE3C1-8DF8-46B4-9B52-918C1119EFC8Q35690523-92DE3F17-4638-43D1-A263-5F4928C24347Q35790256-CFF8B9B2-9D8C-4F3B-90FE-B15B2B067568Q35868716-129BDBFD-735D-415B-929D-CA100AA998D2Q35917555-B59D614B-45BB-4E5E-B59A-D07D1341C164Q36550049-67403EC5-DCF2-4D3A-A01F-04A96A9A0AA0Q36558961-F6E10946-8D73-443A-A74E-60876A08E256Q36761492-CF251DD7-F033-4433-9931-0F0174D2010FQ36899999-AF0C60C0-E8DB-4B64-8B06-1E3E36A8DBF5Q37979704-5107F12B-8817-4ADD-8038-8AA7633CB106Q39410515-46B6B2EB-94A7-43BB-B051-A24702379603Q51041983-FE357BDA-E27F-4A65-A60F-FA7BC8415C7D
P2860
Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Sensitivity and specificity of ...... BI PRISM 3100 genetic analyzer
@ast
Sensitivity and specificity of ...... BI PRISM 3100 genetic analyzer
@en
type
label
Sensitivity and specificity of ...... BI PRISM 3100 genetic analyzer
@ast
Sensitivity and specificity of ...... BI PRISM 3100 genetic analyzer
@en
prefLabel
Sensitivity and specificity of ...... BI PRISM 3100 genetic analyzer
@ast
Sensitivity and specificity of ...... BI PRISM 3100 genetic analyzer
@en
P2093
P2860
P1476
Sensitivity and specificity of ...... BI PRISM 3100 genetic analyzer
@en
P2093
Cheryl Davis
Christina Trevino
Gillian Crutcher
Jeff Fairman
John Kennedy
Kevin Kunstman
Olga Petrauskene
Shawn P Cunningham
P2860
P304
P356
10.1128/JCM.43.2.813-817.2005
P407
P577
2005-02-01T00:00:00Z